The cell therapy manufacturing market involves the development and implementation of cell culture techniques to manufacture therapeutic cells and tissues for human transplantation. Cell therapies are used to treat various chronic and life-threatening diseases such as cancer, neurological disorders, and cardiovascular diseases. Cell therapies offer promising treatment options by replacing or regenerating human cells, tissues, and organs. The manufacturing process involves cell collection, isolation, expansion or activation, formulation, freezing, testing, and storage. Cells and tissues used in therapies include stem cells, chondrocytes, keratinocytes, fibroblasts, and mesenchymal cells.
The global cell therapy manufacturing market is estimated to be valued at US$ 12.99 Mn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The growing demand for regenerative medicines is expected to drive the growth of the cell therapy manufacturing market over the forecast period. Regenerative medicine uses therapeutic cells and tissues to repair, replace, restore, or regenerate damaged or diseased cells, tissues and organs. Cell therapies offer promising treatment options for chronic diseases with high unmet needs. Moreover, advancement in cell culture techniques and bioprocess engineering is facilitating large-scale manufacturing of therapeutic cells. This is expected to boost the commercialization of various cell therapies. Additionally, continuous research in developing new cell types is also fueling the market growth. However, high manufacturing costs associated with cell therapies and lack of skilled professionals in cell processing pose significant challenges to the market.
Segment Analysis
The cell therapy manufacturing market is primarily segmented into consumables and equipment. The consumables segment dominated the market in 2023, accounting for nearly 60% share. This is owing to the recurring use of consumables such as media, serum, reagents, and bioreactors required during cell processing. Within consumables, cell culture consumables held the largest share as they play a key role in cell amplification and maintenance.
PEST Analysis
Political: The market is positively impacted by regulations encouraging the use of cell therapies for treating chronic diseases. For instance, favorable reimbursement policies increase access to advanced therapies.
Economic: Rising healthcare expenditure in major markets and growing focus on reducing healthcare costs through novel therapeutics drive the market.
Social: Increasing prevalence of chronic conditions and ageing population demanding effective treatment modalities support market growth. Acceptance of regenerative therapies among patients supplements the social factors.
Technological: Advancements in cell culture techniques, automated processing systems, and process analytical technologies have enhanced manufacturing efficiencies and product quality. Integration of digital platforms with cell processing aids process optimization.
Key Takeaways
The Global Cell Therapy Manufacturing Market Growth is expected to witness high over the forecast period, driven by the increasing demand for cell therapies in the treatment of chronic diseases.
Regional analysis: North America currently dominates the market aided by presence of large biopharmaceutical companies and strong government support for cell-based research. Asia Pacific is poised to be the fastest growing market anticipated to expand at over 10% CAGR through 2030 led by countries like China, India and South Korea where cell therapies are increasingly utilized.
Key players: Key players operating in the cell therapy manufacturing market are SARAHEALTH SARE, MRK Healthcare Pvt. Ltd., Amkay Products Pvt. Ltd., JIT & JIT, Kanam Latex Industries Pvt. Ltd., RFB Latex Limited, Safeshield Gloves, Amigo Surgicare Pvt. Ltd., Asma Rubber Products Pvt. Ltd., Narang Medical Limited, Phoenix Medical Technologies & Imports, Manglam Medikits Private Limited, and VLHS.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it